THE PROBLEM

Blindness is the most feared human disability. Corneal diseases are one of the most relevant blindness reasons and can be solved only through surgical intervention: any year about 185,00 corneas are transplanted in 116 countries. About 7,500 corneal transplants each year are “doomed to fail”. 12.7 million people are awaiting for transplantation.

STATE OF THE ART

Surgical techniques applied as alternative to transplant, up today, are:

Cataract surgery for lens disease
Artificial retina for retinal disease:
Artificial retina: electrical nerve stimulation of retinal cells

Results:

> 20 years in development
> 100 million $ in funding
Only 350 devices implanted

INTRA-KER SOLUTION

The main problems associated with traditional corneal transplantation are related to immune reactions of rejection, endothelial decay, infection or others similar problems. The innovative solution we propose, as a result of the application of lateral thinking supported by scientific progress and our new findings, is the development and use of an hybrid intracorneal device.

Our hybrid intracorneal device is

EXTRA OCULAR safe implantation

STABLE for storage > 6 month

TRANSPARENT for light transmission

ACELLULAR no immune rejection

BIOLOGIC for bio-integration

BARRIER for globe integrity

INDEPENDENT of endothelial function

WORK IN PROGRESS

2020

Birth of Project

Professor Massimo Busin, applying lateral thinking, begins experimentation to invent an effective alternative to critical cases of corneal transplantation, also easily applicable to the generality of surgeries.

2021

Initial R&D Phase

In collaboration with Eliachar Technology, begins applied research for the use of optical lenses and projectors to replace the diseased cornea.

MARKET FIGURES

185K

Corneas Transplants per Year

116

Countries involved

12.7M

People awaiting for transplantation

Transplants doomed to fail each Year

>10M

Potential Patients per Year